Kimia Bioscien.

{
  "main_header": {
    "sid": 263659,
    "name": "Kimia Bioscien.",
    "stock_name": "Kimia Bioscien.",
    "full_name": "Kimia Biosciences Ltd",
    "name_url": "stocks-analysis/kimia-bioscien",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "30.84",
    "chg": -1.06,
    "chgp": "-3.32%",
    "dir": -1,
    "prev_price": "31.90",
    "mcapval": "147.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 530313,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE285U01025",
    "curr_date": "Jan 19",
    "curr_time": "",
    "bse_nse_vol": "798 ",
    "exc_status": "Active",
    "traded_date": "Jan 19, 2026",
    "traded_date_str": "2026 01 19",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/kimia-bioscien-263659-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Kimia Biosciences Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kimia-biosciences-ltd-is-rated-strong-sell-3781203",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/KimiaBioscience_mojoScore_3781203.png",
        "date": "2026-01-05 10:15:12",
        "description": "Kimia Biosciences Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 September 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 05 January 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Kimia Biosciences Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kimia-biosciences-ltd-is-rated-strong-sell-3768965",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/KimiaBioscience_mojoScore_3768965.png",
        "date": "2025-12-25 12:58:29",
        "description": "Kimia Biosciences Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 Sep 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 December 2025, providing investors with an up-to-date view of the company's fundamentals, returns, and market performance."
      },
      {
        "title": "Kimia Bioscien. Sees Revision in Market Evaluation Amidst Challenging Fundamentals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kimia-bioscien-downgraded-to-strong-sell-amid-weak-fundamentals-and-bearish-outlook-3748063",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/KimiaBioscien_mojoScore_3748063.png",
        "date": "2025-12-05 10:11:01",
        "description": "Kimia Bioscien., a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting shifts in its fundamental and technical outlook. This adjustment follows a detailed reassessment of the company’s quality, valuation, financial trends, and technical indicators, highlighting ongoing challenges in its operational and market performance."
      },
      {
        "title": "Kimia Biosciences Falls to 52-Week Low of Rs.26.09 Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kimia-biosciences-stock-falls-to-52-week-low-of-rs2609-amidst-continued-downtrend-3741786",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/KimiaBioscience_priceRelatedfactors_3741786.png",
        "date": "2025-12-02 12:42:30",
        "description": "Kimia Biosciences touched a fresh 52-week low of Rs.26.09 today, marking a significant decline amid a sustained downward trend. The stock has experienced notable volatility and underperformance relative to its sector and benchmark indices over the past year."
      },
      {
        "title": "Kimia Biosciences Falls to 52-Week Low of Rs.27.2 Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kimia-biosciences-stock-falls-to-52-week-low-of-rs272-amidst-continued-downtrend-3738368",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/KimiaBioscience_priceRelatedfactors_3738368.png",
        "date": "2025-12-01 11:12:33",
        "description": "Kimia Biosciences has reached a new 52-week low of Rs.27.2 today, marking a significant decline in its stock price amid a sustained downward trend over recent sessions. The pharmaceutical and biotechnology company’s shares have underperformed both its sector and broader market indices, reflecting ongoing pressures on its valuation and financial metrics."
      },
      {
        "title": "Kimia Biosciences Falls to 52-Week Low of Rs.27.2 Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kimia-biosciences-stock-falls-to-52-week-low-of-rs272-amidst-continued-downtrend-3738369",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/KimiaBioscience_priceRelatedfactors_3738369.png",
        "date": "2025-12-01 11:12:33",
        "description": "Kimia Biosciences has reached a new 52-week low of Rs.27.2, marking a significant decline in its stock price amid a sustained downward trend over recent days. The pharmaceutical and biotechnology company’s shares have underperformed relative to its sector and broader market indices, reflecting ongoing pressures on its valuation and financial metrics."
      },
      {
        "title": "Kimia Biosciences Falls to 52-Week Low of Rs.28.4 Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kimia-biosciences-stock-falls-to-52-week-low-of-rs284-3735819",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/KimiaBioscience_priceRelatedfactors_3735819.png",
        "date": "2025-11-28 15:07:24",
        "description": "Kimia Biosciences has reached a new 52-week low of Rs.28.4 today, marking a significant decline in its stock price amid ongoing downward momentum. The stock has experienced notable volatility and underperformance relative to its sector and benchmark indices."
      },
      {
        "title": "Why is Kimia Bioscien. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-kimia-bioscien-fallingrising-3721872",
        "imagepath": "",
        "date": "2025-11-22 00:31:22",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Stock Performance Against Benchmarks</strong></p>\n<p>Kimia Biosciences has underperformed markedly compared to the broader market indices over multiple time horizons. Over the past week, the stock declined by 7.59%, while the Sensex gained 0.79%. This negative trend extends over longer periods, with the stock falling 8.83% in the last month and a steep 30.59% over the past year, contrasting sharply with the Sensex’s 10.47% gain during the same period. Even over three and five years, the stock has lagged significantly, registering losses of 19.88% and 26.81% respectively, while the Sensex surged by 39.39% and 94.23%. These figures underscore persistent underperformance and investor caution surrounding the company.</p>\n<p><strong>Intraday Volatility and Trading Patterns</strong></p>\n<p>On 21-N..."
      },
      {
        "title": "Kimia Biosciences Q2 FY26: Margin Compression Overshadows Revenue Growth",
        "link": "https://www.marketsmojo.com/news/result-analysis/kimia-biosciences-q2-fy26-margin-compression-overshadows-revenue-growth-3718748",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/KimiaBioscience_quaterlyResult_3718748.png",
        "date": "2025-11-18 16:37:16",
        "description": "Kimia Biosciences Ltd., a Gurgaon-based pharmaceutical company specialising in bulk drug manufacturing, reported net profit of ₹1.02 crores for Q2 FY26, marking a sequential increase of 70.00% from ₹0.60 crores in Q1 FY26. However, year-on-year comparison reveals a concerning decline of 36.65% from ₹1.61 crores in Q2 FY25. The company's stock, trading at ₹34.00 with a modest market capitalisation of ₹159 crores, has struggled significantly, declining 27.66% over the past year whilst the broader Sensex gained 9.48%."
      }
    ],
    "total": 174,
    "sid": "263659",
    "stock_news_url": "https://www.marketsmojo.com/news/kimia-biosciences-263659"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "10-Jan-2026",
      "details": "Certificate pursuant to Regulation 74(5) of the SEBI(Depositories and participants)Regulations2018",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
      "datetime": "07-Jan-2026",
      "details": "Intimation under regulation 30 of SEBI(LODR) regulations2015-appointment of chief financial officer(CFO) Key Managerial Personnel",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)",
      "datetime": "06-Jan-2026",
      "details": "Announcement under Regulation 30(LODR) -Resignation of Chief Financial officer",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Kimia Biosciences Ltd is Rated Strong Sell

2026-01-05 10:15:12

Kimia Biosciences Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 September 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 05 January 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Kimia Biosciences Ltd is Rated Strong Sell

2025-12-25 12:58:29

Kimia Biosciences Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 Sep 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 December 2025, providing investors with an up-to-date view of the company's fundamentals, returns, and market performance.

Read full news article

Kimia Bioscien. Sees Revision in Market Evaluation Amidst Challenging Fundamentals

2025-12-05 10:11:01

Kimia Bioscien., a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting shifts in its fundamental and technical outlook. This adjustment follows a detailed reassessment of the company’s quality, valuation, financial trends, and technical indicators, highlighting ongoing challenges in its operational and market performance.

Read full news article

Kimia Biosciences Falls to 52-Week Low of Rs.26.09 Amidst Continued Downtrend

2025-12-02 12:42:30

Kimia Biosciences touched a fresh 52-week low of Rs.26.09 today, marking a significant decline amid a sustained downward trend. The stock has experienced notable volatility and underperformance relative to its sector and benchmark indices over the past year.

Read full news article

Kimia Biosciences Falls to 52-Week Low of Rs.27.2 Amidst Continued Downtrend

2025-12-01 11:12:33

Kimia Biosciences has reached a new 52-week low of Rs.27.2 today, marking a significant decline in its stock price amid a sustained downward trend over recent sessions. The pharmaceutical and biotechnology company’s shares have underperformed both its sector and broader market indices, reflecting ongoing pressures on its valuation and financial metrics.

Read full news article

Kimia Biosciences Falls to 52-Week Low of Rs.27.2 Amidst Continued Downtrend

2025-12-01 11:12:33

Kimia Biosciences has reached a new 52-week low of Rs.27.2, marking a significant decline in its stock price amid a sustained downward trend over recent days. The pharmaceutical and biotechnology company’s shares have underperformed relative to its sector and broader market indices, reflecting ongoing pressures on its valuation and financial metrics.

Read full news article

Kimia Biosciences Falls to 52-Week Low of Rs.28.4 Amidst Continued Downtrend

2025-11-28 15:07:24

Kimia Biosciences has reached a new 52-week low of Rs.28.4 today, marking a significant decline in its stock price amid ongoing downward momentum. The stock has experienced notable volatility and underperformance relative to its sector and benchmark indices.

Read full news article

Why is Kimia Bioscien. falling/rising?

2025-11-22 00:31:22

Stock Performance Against Benchmarks

Kimia Biosciences has underperformed markedly compared to the broader market indices over multiple time horizons. Over the past week, the stock declined by 7.59%, while the Sensex gained 0.79%. This negative trend extends over longer periods, with the stock falling 8.83% in the last month and a steep 30.59% over the past year, contrasting sharply with the Sensex’s 10.47% gain during the same period. Even over three and five years, the stock has lagged significantly, registering losses of 19.88% and 26.81% respectively, while the Sensex surged by 39.39% and 94.23%. These figures underscore persistent underperformance and investor caution surrounding the company.

Intraday Volatility and Trading Patterns

On 21-N...

Read full news article

Kimia Biosciences Q2 FY26: Margin Compression Overshadows Revenue Growth

2025-11-18 16:37:16

Kimia Biosciences Ltd., a Gurgaon-based pharmaceutical company specialising in bulk drug manufacturing, reported net profit of ₹1.02 crores for Q2 FY26, marking a sequential increase of 70.00% from ₹0.60 crores in Q1 FY26. However, year-on-year comparison reveals a concerning decline of 36.65% from ₹1.61 crores in Q2 FY25. The company's stock, trading at ₹34.00 with a modest market capitalisation of ₹159 crores, has struggled significantly, declining 27.66% over the past year whilst the broader Sensex gained 9.48%.

Read full news article

View All News